Alvesco · DIN 02285614 · 200 mcg/Actuation · inhaler, 120 doses
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Alvesco · DIN 02285614
Manufacturer: Covis Pharma B.V.; listing date 2007-06-06
Health Canada: Marketed since 2021-02-10 · brand ALVESCO · ATC R03BA08 CICLESONIDE · form Aerosol (metered-dose) · route Inhalation · ingredients CICLESONIDE 200 MCG/ACT · company Covis pharma gmbh · schedule Prescription
Alvesco: Formulary list price $93.30 per unit (the source does not state the unit; exact figure $93.3000). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02285614)
Source record
DIN 02285614: Alvesco
Raw flags: sec3=Y
Item: 680400094; group id 706; item number 1744; lccId None; manufacturer id COV
Source form: Inh-120 Dose Pk; strength: 200mcg/Actuation
Recorded listing: General benefit
Source prices (unrounded): $93.3000; ministry $93.3000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02285614
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77112
Shortage status: not checked (no credentials)